BRPI0418582A - opioid delivery system - Google Patents
opioid delivery systemInfo
- Publication number
- BRPI0418582A BRPI0418582A BRPI0418582-0A BRPI0418582A BRPI0418582A BR PI0418582 A BRPI0418582 A BR PI0418582A BR PI0418582 A BRPI0418582 A BR PI0418582A BR PI0418582 A BRPI0418582 A BR PI0418582A
- Authority
- BR
- Brazil
- Prior art keywords
- opioid
- administration
- formulation
- pulmonary
- delivery system
- Prior art date
Links
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 230000036592 analgesia Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000013583 drug formulation Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000007726 management method Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 238000012383 pulmonary drug delivery Methods 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
SISTEMA DE ADMINISTRAçãO DE OPIóIDES Uma formulação de opióide para administração pulmonar no tratamento ou gerenciamento de dor, que contém um dispositivo de administração de fármaco pulmonar, método de administração, que contém um kit e usos da mesma. A formulação contém pelo menos um opióide de início rápido e preferivelmente também contém um opióide de efeito prolongado para reduzir a freqüêcia de administração. A invenção emprega os efeitos colaterais da formulação de opióide para permitir que os pacientes autolimitem a ingestão de fámaco e, com evite a toxicidade enquanto se atinge analgesia. Emprega-se um modelo farmacocinético e farmacodinâmico para determinar as formulações de fármaco ideais e os parâmetros ideais para administração.OPIOID ADMINISTRATION SYSTEM An opioid formulation for pulmonary administration in the treatment or management of pain, which contains a pulmonary drug delivery device, method of administration, which contains a kit and uses thereof. The formulation contains at least one rapid onset opioid and preferably also contains a long acting opioid to reduce the frequency of administration. The invention employs the side effects of the opioid formulation to allow patients to self-limit drug intake and to avoid toxicity while achieving analgesia. A pharmacokinetic and pharmacodynamic model is employed to determine the ideal drug formulations and the optimal parameters for administration.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45033303P | 2003-02-28 | 2003-02-28 | |
| PCT/CA2004/000303 WO2004075879A1 (en) | 2003-02-28 | 2004-03-01 | Opioid delivery system |
| PCT/CA2004/001578 WO2005082369A1 (en) | 2003-02-28 | 2004-08-27 | Opioid delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0418582A true BRPI0418582A (en) | 2007-06-19 |
Family
ID=40635740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0418582-0A BRPI0418582A (en) | 2003-02-28 | 2004-08-27 | opioid delivery system |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0418582A (en) |
-
2004
- 2004-08-27 BR BRPI0418582-0A patent/BRPI0418582A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0416796A (en) | organic compounds | |
| SE0201669D0 (en) | New formulation and use thereof | |
| EA200601799A1 (en) | HYDRAZIDE-CONTAINING COMPOUNDS - CFTR INHIBITORS AND THEIR APPLICATION | |
| CY1106430T1 (en) | MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG | |
| CY1111159T1 (en) | CONCENTRATED Methotrexate Solutions | |
| BRPI0416801A (en) | 1h-imidazoquinoline derivatives as protein synase inhibitors | |
| ATE232384T1 (en) | COMPOSITIONS FOR TREATING NICOTINE DEPENDENCE CONTAINING MECAMYLAMIN AND BUPROPION | |
| GB0211649D0 (en) | Organic compounds | |
| NO20065878L (en) | Therapeutic compounds | |
| SE0102276D0 (en) | Device and method for administering a drug | |
| BRPI0412526A (en) | compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition | |
| BRPI0309544B8 (en) | storage stable oral pharmaceutical preparation comprising oxycodone and naloxone | |
| TR200001891T2 (en) | ASPB28- Human insulin and its use. | |
| DK1256339T3 (en) | Transdermal therapeutic system for obtaining high plasma levels of rotigotine in the treatment of Parkinson's disease | |
| EP1799865A4 (en) | METHODS OF ADMINISTERING ILOPERIDONE | |
| EP1680110A4 (en) | ONCE DAILY DOSAGE FORMS OF TROSPIUM | |
| CY1119580T1 (en) | NEW MEDICINAL PREPARATIONS USEFUL IN HEALTH CARE | |
| DK1383752T3 (en) | Deuterated 3-piperidinopropiophenones as well as drugs containing these compounds | |
| EA200601846A1 (en) | CONTAINING BENZOXASINS MEDICINAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF RESPIRATORY TRACKS | |
| UY27759A1 (en) | COMBINATIONS OF DRUGS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTI-POLYNERGIC AGENT. | |
| DE602005019043D1 (en) | Glucagonone receptor agonists, their preparation and their therapeutic use | |
| EA200602092A1 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF RHINITIS | |
| CY1107231T1 (en) | Substituted 4-Aminocyclohexanol derivatives | |
| CY1109215T1 (en) | OPTIONAL ADMINISTRATION SYSTEM | |
| BRPI0412430A (en) | zot and zonulin receptor agonist polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: YM BIOSCIENCES INC. (CA) Free format text: TRANSFERIDO DE: DELEX THERAPEUTICS INC. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |